5,465
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Microinvasive Glaucoma Surgery: An Evidence-Based Review

, &
Pages 772-786 | Received 31 Dec 2020, Accepted 06 Feb 2021, Published online: 23 Jul 2021

References

  • Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012 May;153(5):789–803.
  • Ma AK, Lee JH, Warren JL, Teng CC. GlaucoMap – distribution of glaucoma surgical procedures in the United States. Clin Ophthalmol. 2020;Volume 14:2551–2560. doi:10.2147/OPTH.S257361.
  • Rathi S, Andrews CA, Greenfield DS, Stein JD. Trends in Glaucoma surgeries performed by Glaucoma subspecialists versus nonsubspecialists on medicare beneficiaries from 2008 through 2016. Ophthalmology. 2020;128(1):30–38. doi:10.1016/j.ophtha.2020.06.051.
  • Saheb H, Ahmed IIK. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012 March;23(2):96–104. doi:10.1097/ICU.0b013e32834ff1e7.
  • Anand N, Klug E, Nirappel A, et al. A Review of Cyclodestructive Procedures for the Treatment of Glaucoma. Seminars in Ophthalmology. 2020;25(5–6):261–275.
  • Samuelson TW, Sarkisian SR, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular mico-bypass in primary open-angle glaucoma and cataract: two year results. Ophthalmology. 2019;126(6):811–821. doi:10.1016/j.ophtha.2019.03.006.
  • Samuelson TW, Chang DF, Marquis R, et al. A schlemm canal microstent for intraocular pressure reduction in primary open-angle Glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126(1):29–37.doi:10.1016/j.ophtha.2018.05.012.
  • Schehlein EM, Kaleem MA, Swamy R, Saeedi OJ. Microinvasive Glaucoma surgery: an evidence-based assessment. Expert Rev Ophthalmol. 2017;12(4):331–343. doi:10.1080/17469899.2017.1335597.
  • Minckler D, Mosaed S, Dustin L, Francis B, Group TS. Trabectome (Trabeculectomy-Internal Approach): additional experience and extended follow-up. Trans Am Ophthalmol Soc. 2008;106:149–160.
  • Mizoguchi T, Nishigaki S, Sato T, Wakiyama H, Ogino N. Clinical results of Trabectome surgery for open-angle glaucoma. Clin Ophthalmol. 2015;9:1889–1894. doi:10.2147/OPTH.S83958.
  • Bussel II, Kaplowitz K, Schuman JS, Loewen NA. Outcomes of ab interno trabeculectomy with the trabectome after failed trabeculectomy. Br J Ophthalmol. 2015;99(2):258–262. doi:10.1136/bjophthalmol-2013-304717.
  • Dang Y, Roy P, Bussel II, Loewen RT, Parikh H, Loewen NA. Combined analysis of trabectome and phaco-trabectome outcomes by glaucoma severity. F1000Res. 2016;5:762. doi:10.12688/f1000research.8448.2.
  • Parikh HA, Bussel II, Schuman JS, Brown EN, Loewen NA. Coarsened exact matching of phaco-trabectome to trabectome in phakic patients: lack of additional pressure reduction from phacoemulsification. Plos One. 2016 Feb;11(2):e0149384. doi:10.1371/journal.pone.0149384.
  • Esfandari H, Shah P, Torkian P, et al. Five-year clinical outcomes of combined phacoemulsification and trabectome surgery at a single glaucoma center. Graefes Arch Clin Exp Ophthalmol. 2019;257(2):357–362. doi:10.1007/s00417-018-4146-y.
  • Yousef AY, Strzalkowska A, Hillenkamp J, Rosentreter A, Loewen NA. Comparison of a second-generation trabecular bypass (iStent inject) to ab interno trabeculectomy (Trabectome) by exact matching. Graefe’s Archive for Clinical and Experimental Ophthalmology. Arch Clin Exp Ophthalmol. 2020;258(12):2775–2780. doi:10.1007/s00417-020-04933-z. 2020.
  • Real-world Case MD. Series of iStent or iStent inject Trabecular micro-bypass stents combined with cataract surgery. Ophthalmol Ther. 2019;8(4):549–561. doi:10.1007/s40123-019-00208-x.
  • Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A. Intermediate results of iStent or iStent inject implantation combined with cataract surgery in a real-world setting: a longitudinal retrospective study. Ophthalmol Ther. 2019;8(1):87–100. doi:10.1007/s40123-019-0166-x.
  • Salimi A, Lapointe J, One-Year HP. Outcomes of second-generation trabecular micro-bypass stents (iStent Inject) implantation with cataract surgery in different Glaucoma subtypes and severities. Ophthalmol Ther. 2019;8(4):563–575. doi:10.1007/s40123-019-00214-z.
  • Neuhann R, Neuhann T. Second-generation trabecular micro-bypass stent implantation: retrospective analysis after 12- and 24-month follow-up. Eye and Vision. 2020;7(1):1. doi:10.1186/s40662-019-0169-7.
  • Fea AM, Belda JI, Rękas M, et al. Prospective unmasked randomized evaluation of the iStent inject (®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clinical Ophthalmology. 2014;8:875–882. Published 2014 May 7. doi:10.2147/OPTH.S59932
  • Voskanyan L, García-Feijoó J, Belda JI, Fea A, Jüneman A, Prospective BC. Unmasked Evaluation of the iStent Inject system for open-angle Glaucoma: synergy trial. Adv Ther. 2014;31(2):189–201. doi:10.1007/s12325-014-0095-y.
  • Hengerer FH, Auffarth GU, Riffel C, Second-Generation Trabecular C-HI. Micro-Bypass stents as standalone treatment for Glaucoma: a 36-Month Prospective Study. Adv Ther. 2019;36(7):1606–1617. doi:10.1007/s12325-019-00984-9.
  • Dorairaj SK, Kahook MY, Williamson BK, Seibold LK, ElMallah MK, Singh IP. A multicenter retrospective comparison of goniotomy versus trabecular bypass device implantation in glaucoma patients undergoing cataract extraction. Clin Ophthalmol. 2018;12:791–797.
  • Lee D, King J, Thomsen S, Hirabayashi M, Comparison AJ. Of surgical outcomes between excisional goniotomy using the Kahook Dual Blade and iStent Trabecular micro-bypass stent in combination with phacoemulsification. Clin Ophthalmol. 2019;13:2097–2102. doi:10.2147/OPTH.S224109.
  • Ahmed IIK, Fea A, Au L, et al. A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: the COMPARE study. Ophthalmology. 2020;127(1):52–56. doi:10.1016/j.ophtha.2019.04.034.
  • Dorairaj S, Tam MD. Kahook Dual Blade Excisional Goniotomy and Goniosynechialysis combined with phacoemulsification for angle-closure Glaucoma: 6-month results. J Glaucoma. 2019;28(7):643–646. doi:10.1097/IJG.0000000000001256.
  • ElMallah MK, Berdahl JP, Williamson BK. et al. Twelve-month outcomes of stand-alone excisional goniotomy in mild to severe Glaucoma. Clin Ophthalmol. 2020;14:1891–1897. doi:10.2147/OPTH.S256423.
  • Sieck EG, Epstein RS, Kennedy JB, et al. Outcomes of Kahook Dual Blade Goniotomy with and without phacoemulsification cataract extraction. Ophthalmol Glaucoma. 2018;1(1):75–81.doi:10.1016/j.ogla.2018.06.006.
  • Miller VJ, Young CEC, SooHoo JR, et al. Efficacy of Goniotomy with Kahook Dual Blade in patients with uveitis-associated ocular hypertension. J Glaucoma. 2019;28(8):744–748.doi:10.1097/IJG.0000000000001298.
  • Berdahl JP, Gallardo MJ, ElMallah MK, et al. Six-month outcomes of goniotomy performed with the Kahook Dual Blade as a stand-alone Glaucoma procedure. Adv Ther. 2018;35(11):2093–2102.doi:10.1007/s12325-018-0803-0.
  • Salinas L, Chaudhary A, Berdahl JP, et al. Goniotomy using the Kahook Dual Blade in severe and refractory glaucoma: 6-month outcomes. J Glaucoma. 2018;27(10):849–855.doi:10.1097/IJG.0000000000001019.
  • Hirabayashi MT, Lee D, King JT, Thomsen S, An JA. Comparison Of Surgical Outcomes Of 360° Circumferential Trabeculotomy Versus Sectoral Excisional Goniotomy With The Kahook Dual Blade At 6 Months. Clin Ophthalmol. 2019;13:2017–2024. doi:10.2147/OPTH.S208468.
  • Reitsamer H, Sng C, Lenzhofer M, Barton K, Stalmans I, Group AS. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):983–996. doi:10.1007/s00417-019-04251-z.
  • Olgun A, Aktas Z, Ucgul A. XEN gel implant versus gonioscopy-assisted transluminal trabeculotomy for the treatment of open-angle glaucoma. Int Ophthalmol. 2020;40(5):1085–1093. doi:10.1007/s10792-019-01271-w.
  • Ucar F, Cetinkaya S. Xen implantation in patients with primary open-angle glaucoma: comparison of two different techniques. Int Ophthalmol. 2020;40(10):2487–2494. doi:10.1007/s10792-020-01427-z.
  • Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25–26. doi:10.1016/j.ajo.2017.07.023.
  • Panarelli JF, Yan DB, Francis B, Craven ER. XEN gel stent open conjunctiva technique: a practical approach paper. Adv Ther. 2020;37(5):2538–2549. doi:10.1007/s12325-020-01278-1.
  • Mansouri K, Guidotti J, Rao HL, et al. Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results. J Glaucoma. Feb 2018;27(2):140–147. doi:10.1097/IJG.0000000000000858.
  • Jones J, Koch DD, Vold S, et al. Results from the United States cohort of the HORIZON trial of a schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma. J Cataract Refrac Surg. 2019;45(9):1305–1315. doi:10.1016/j.jcrs.2019.03.024.
  • Laspas P, Garcia-Feijoo J, Martinez-de-la-casa JM, et al. Three-year results of hydrus microstent with phacoemulsification. Ophthalmology Glaucoma. 2019;2(6):440–442. doi:10.1016/j.ogla.2019.08.006.